Potential of Immunological Markers IL-1β, IL-10, IL-1ra, and IL-6 for Distinguishing Clinical Conditions (StSt, VOC, and CV) in SCA Patients. The gene discussed is IL6; the disease is autosomal dominant cerebellar ataxia.